{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:22:33Z","timestamp":1781940153808,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"\u201cQimingxing\u201d Research Fund for Young Talents of West China Hospital","award":["No. HXQMX0105"],"award-info":[{"award-number":["No. HXQMX0105"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The differences in clinicopathological features and prognosis between familial non-medullary thyroid carcinoma (FNMTC) and sporadic non-medullary thyroid carcinoma (SNMTC) remain a subject of debate. This study aims to compare the clinicopathological features and recurrence-free survival (RFS) between FNMTC and SNMTC, with a particular focus on the subgroup differences based on the number of affected relatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was conducted on 672 NMTC patients who underwent thyroidectomy at West China Hospital between 2015 and 2024. The cohort included 224 FNMTC patients (from 98 families) and 448 SNMTC patients. FNMTC patients were further stratified into families with two affected members (FNMTC-2,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009160) and families with \u2265\u2009three affected members (FNMTC-3,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200964) subgroups. Clinicopathological characteristics and RFS were compared among the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to the SNMTC group, the FNMTC group demonstrated a smaller tumor diameter (1.03\u2009\u00b1\u20090.60\u00a0cm vs. 1.15\u2009\u00b1\u20090.96\u00a0cm,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0255) but higher rates of multifocality (43.75% vs. 34.82%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024), bilaterality (32.59% vs. 23.88%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0163), and lymph node metastasis (52.68% vs. 44.42%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0432). Subgroup analysis revealed that the FNMTC-3 group, compared to SNMTC, was associated with a younger age at diagnosis (43.76\u2009\u00b1\u200914.53 vs. 47.01\u2009\u00b1\u200911.28 years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039), a smaller tumor diameter (0.89\u2009\u00b1\u20090.46\u00a0cm vs. 1.15\u2009\u00b1\u20090.96\u00a0cm,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0343), and increased rates of multifocality (50.00% vs. 34.82%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0185), bilaterality (37.50% vs. 23.88%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0195), lymph node metastasis (57.81% vs. 44.42%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0444), and thyroid follicular nodular disease (57.81% vs. 44.20%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0409). Furthermore, the FNMTC-3 group had a significantly smaller tumor diameter than the FNMTC-2 group (0.89\u2009\u00b1\u20090.46\u00a0cm vs. 1.08\u2009\u00b1\u20090.64\u00a0cm,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0343). However, no statistically significant differences in RFS were observed among the SNMTC and FNMTC groups during follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FNMTC-3 exhibits more aggressive clinicopathological features than SNMTC, including earlier onset, higher multifocality, bilaterality, and metastatic potential. These findings support that the number of affected family members is a significant indicator of tumor aggressiveness in FNMTC. Although no difference in RFS was observed, the distinct pathological profile of FNMTC-3 warrants more vigilant surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04357-9","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:19:25Z","timestamp":1776237565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and prognosis of familial non-medullary thyroid carcinoma: a retrospective study of 98 families"],"prefix":"10.1186","volume":"24","author":[{"given":"Guang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-9129","authenticated-orcid":false,"given":"Tao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"3","key":"4357_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"Cancer J Clin"},{"key":"4357_CR2","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975\u20132014. National Cancer Institute, Bethesda, MD. 2017. https:\/\/seer.cancer.gov\/csr\/1975_2014."},{"issue":"6","key":"4357_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1089\/thy.2005.15.588","volume":"15","author":"C Sturgeon","year":"2005","unstructured":"Sturgeon C, Clark OH. Familial nonmedullary thyroid cancer. Thyroid. 2005;15(6):588\u201393. https:\/\/doi.org\/10.1089\/thy.2005.15.588.","journal-title":"Thyroid"},{"issue":"1","key":"4357_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12022-022-09705-5","volume":"33","author":"V Nos\u00e9","year":"2022","unstructured":"Nos\u00e9 V, Gill A, Teijeiro JMC, Perren A, Erickson L. Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes. Endocr Pathol. 2022;33(1):197\u2013227. https:\/\/doi.org\/10.1007\/s12022-022-09705-5.","journal-title":"Endocr Pathol"},{"issue":"1","key":"4357_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.23736\/S2724-6507.20.03338-6","volume":"46","author":"V Cirello","year":"2021","unstructured":"Cirello V. Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors. Minerva Endocrinol. 2021;46(1):5\u201320. https:\/\/doi.org\/10.23736\/S2724-6507.20.03338-6.","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"4357_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1530\/EJE-13-0865","volume":"170","author":"AE Pinto","year":"2013","unstructured":"Pinto AE, Silva GL, Henrique R, Menezes FD, Teixeira MR, Leite V, Cavaco BM. Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical\/prognostic behaviour. Eur J Endocrinol. 2013;170(2):321\u20137. https:\/\/doi.org\/10.1530\/EJE-13-0865.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"4357_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/thy.2011.0163","volume":"22","author":"YJ Park","year":"2012","unstructured":"Park YJ, Ahn HY, Choi HS, Kim KW, Park DJ, Cho BY. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid. 2012;22(4):356\u201362. https:\/\/doi.org\/10.1089\/thy.2011.0163.","journal-title":"Thyroid"},{"issue":"1","key":"4357_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/thy.2011.0192","volume":"22","author":"H Mazeh","year":"2012","unstructured":"Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid. 2012;22(1):3\u20138. https:\/\/doi.org\/10.1089\/thy.2011.0192.","journal-title":"Thyroid"},{"key":"4357_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2015.00117","volume":"6","author":"M Tavarelli","year":"2015","unstructured":"Tavarelli M, Russo M, Terranova R, Scollo C, Spadaro A, Sapuppo G, Malandrino P, Masucci R, Squatrito S, Pellegriti G. Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families. Front Endocrinol. 2015;6:117. https:\/\/doi.org\/10.3389\/fendo.2015.00117.","journal-title":"Front Endocrinol"},{"key":"4357_CR10","doi-asserted-by":"publisher","first-page":"1200855","DOI":"10.3389\/fendo.2023.1200855","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Zhang H, Yan Y, Li X, Jia M, Zhou H, Lu X. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases. Front Endocrinol. 2023;14:1200855. https:\/\/doi.org\/10.3389\/fendo.2023.1200855.","journal-title":"Front Endocrinol"},{"key":"4357_CR11","doi-asserted-by":"publisher","first-page":"616974","DOI":"10.3389\/fonc.2021.616974","volume":"11","author":"T Yang","year":"2021","unstructured":"Yang T, Huang L, Chen C, Luo H, Jiang Y. Comparison Between Clinicopathological Characteristics, BRAF V600E and TERT Promoter Mutation of Familial Non-Medullary Thyroid Carcinomas, and Sporadic Case. Front Oncol. 2021;11:616974. https:\/\/doi.org\/10.3389\/fonc.2021.616974.","journal-title":"Front Oncol"},{"issue":"4","key":"4357_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/thy.2010.0256","volume":"21","author":"W Moses","year":"2011","unstructured":"Moses W, Weng J, Kebebew E. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid: official J Am Thyroid Association. 2011;21(4):367\u201371. https:\/\/doi.org\/10.1089\/thy.2010.0256.","journal-title":"Thyroid: official J Am Thyroid Association"},{"key":"4357_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04413-6","author":"G Yang","year":"2025","unstructured":"Yang G, Tian Y, Zhang Y, Ran Y, Fan Y, Li P, Zheng X, Wei T. Relationship between affected family members and clinical aggressiveness in Familial non-medullary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2025. Advance online publication. https:\/\/doi.org\/10.1007\/s12020-025-04413-6.\u00a0","journal-title":"Endocrine"},{"issue":"2","key":"4357_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/thy.2006.16.181","volume":"16","author":"ND Charkes","year":"2006","unstructured":"Charkes ND. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid. 2006;16(2):181\u20136. https:\/\/doi.org\/10.1089\/thy.2006.16.181.","journal-title":"Thyroid"},{"key":"4357_CR15","doi-asserted-by":"publisher","first-page":"829103","DOI":"10.3389\/fendo.2022.829103","volume":"13","author":"M S\u00e1nchez-Ares","year":"2022","unstructured":"S\u00e1nchez-Ares M, Cameselle-Garc\u00eda S, Abdulkader-Nallib I, Rodr\u00edguez-Carnero G, Beiras-Sarasquete C, Pu\u00f1al-Rodr\u00edguez JA, Cameselle-Teijeiro JM. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys. Front Endocrinol. 2022;13:829103. https:\/\/doi.org\/10.3389\/fendo.2022.829103.","journal-title":"Front Endocrinol"},{"key":"4357_CR16","doi-asserted-by":"publisher","unstructured":"Health Commission Of The People\u2019s Republic Of China N. National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version). Chin J cancer Res = Chung-kuo yen cheng yen chiu. 2022;34(3):131\u201350. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2022.03.01.","DOI":"10.21147\/j.issn.1000-9604.2022.03.01"},{"issue":"6","key":"4357_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11912-019-0799-x","volume":"21","author":"DK Zanoni","year":"2019","unstructured":"Zanoni DK, Patel SG, Shah JP. Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications. Curr Oncol Rep. 2019;21(6):52. https:\/\/doi.org\/10.1007\/s11912-019-0799-x.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"4357_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"issue":"1","key":"4357_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ijc.35159","volume":"156","author":"C Pires","year":"2025","unstructured":"Pires C, Marques IJ, Saramago A, Moura MM, Pojo M, Cabrera R, Santos C, Ros\u00e1rio F, Lousa D, Vicente JB, Bandeiras TM, Teixeira MR, Leite V, Cavaco BM. Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways. Int J Cancer. 2025;156(1):130\u201344. https:\/\/doi.org\/10.1002\/ijc.35159.","journal-title":"Int J Cancer"},{"issue":"8","key":"4357_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4103\/0366-6999.155075","volume":"128","author":"YF Fan","year":"2015","unstructured":"Fan YF, Zhang B, Yang X, Shang ZH, Liu HF, Xie Y, Liu YW, Gao WS, Wu Q, Li XY. Clinicopathologic features of familial nonmedullary thyroid carcinoma. Chin Med J. 2015;128(8):1037\u201341. https:\/\/doi.org\/10.4103\/0366-6999.155075.","journal-title":"Chin Med J"},{"key":"4357_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.oraloncology.2019.05.023","volume":"94","author":"WR Choi","year":"2019","unstructured":"Choi WR, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. Oral Oncol. 2019;94:106\u201310. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.05.023.","journal-title":"Oral Oncol"},{"issue":"14","key":"4357_CR22","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.3390\/cancers15143596","volume":"15","author":"Y Kim","year":"2023","unstructured":"Kim Y, An S, Park J, Bae JS, Kim JS, Kim K. Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study. Cancers. 2023;15(14):3596. https:\/\/doi.org\/10.3390\/cancers15143596.","journal-title":"Cancers"},{"issue":"20","key":"4357_CR23","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.3390\/cancers17203381","volume":"17","author":"CR Lee","year":"2025","unstructured":"Lee CR, Kim JK, Ho J, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY. Familial Non-Medullary Thyroid Carcinoma: Distinct Clinicopathological Features and Prognostic Implications in a Large Cohort of 46,572 Patients. Cancers. 2025;17(20):3381. https:\/\/doi.org\/10.3390\/cancers17203381.","journal-title":"Cancers"},{"issue":"8","key":"4357_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"Ringel MD, Sosa JA, Baloch Z, Bischoff L, Bloom G, Brent GA, Brock PL, Chou R, Flavell RR, Goldner W, Grubbs EG, Haymart M, Larson SM, Leung AM, Osborne JR, Ridge JA, Robinson B, Steward DL, Tufano RP, Wirth LJ. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid. 2025;35(8):841\u2013985. https:\/\/doi.org\/10.1177\/10507256251363120.","journal-title":"Thyroid"},{"issue":"2","key":"4357_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.semnuclmed.2010.10.003","volume":"41","author":"TA Moo","year":"2011","unstructured":"Moo TA, Fahey TJ 3rd. Lymph node dissection in papillary thyroid carcinoma. Semin Nucl Med. 2011;41(2):84\u20138. https:\/\/doi.org\/10.1053\/j.semnuclmed.2010.10.003.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"4357_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s12020-020-02250-3","volume":"68","author":"SA Ammar","year":"2020","unstructured":"Ammar SA, Alobuia WM, Kebebew E. An update on familial nonmedullary thyroid cancer. Endocrine. 2020;68(3):502\u20137. https:\/\/doi.org\/10.1007\/s12020-020-02250-3.","journal-title":"Endocrine"},{"issue":"10","key":"4357_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ejso.2016.08.006","volume":"42","author":"IJ Nixon","year":"2016","unstructured":"Nixon IJ, Su\u00e1rez C, Simo R, Sanabria A, Angelos P, Rinaldo A, Rodrigo JP, Kowalski LP, Hartl DM, Hinni ML, Shah JP, Ferlito A. The impact of family history on non-medullary thyroid cancer. Eur J Surg Oncol. 2016;42(10):1455\u201363. https:\/\/doi.org\/10.1016\/j.ejso.2016.08.006.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"4357_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1089\/thy.2019.0774","volume":"30","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Yu T, Chen L, Xie D, Wang F, Fu L, Cheng C, Li Y, Zhu X, Miao G. A Germline CHEK2 Mutation in a Family with Papillary Thyroid Cancer. Thyroid. 2020;30(6):924\u201330. https:\/\/doi.org\/10.1089\/thy.2019.0774.","journal-title":"Thyroid"},{"issue":"4","key":"4357_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng.339","volume":"41","author":"J Gudmundsson","year":"2009","unstructured":"Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Stefansson K. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 2009;41(4):460\u20134. https:\/\/doi.org\/10.1038\/ng.339.","journal-title":"Nat Genet"},{"issue":"6","key":"4357_CR30","doi-asserted-by":"publisher","first-page":"djv415","DOI":"10.1093\/jnci\/djv415","volume":"108","author":"T Zhang","year":"2016","unstructured":"Zhang T, Xing M. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer. J Natl Cancer Inst. 2016;108(6):djv415. https:\/\/doi.org\/10.1093\/jnci\/djv415.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"4357_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: Rev JAMA. 2024;331(5):425\u201335. https:\/\/doi.org\/10.1001\/jama.2023.26348.","journal-title":"Thyroid Cancer: Rev JAMA"},{"issue":"5","key":"4357_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/thy.2023.0564","volume":"34","author":"YJ Jiang","year":"2024","unstructured":"Jiang YJ, Xia Y, Hu YX, Han ZJ, Guo AY, Huang T. Identification of P21 (CDKN1A) activated kinase 4 as a susceptibility gene for Familial Non-Medullary thyroid carcinoma. Thyroid. 2024;34(5):583\u201397. https:\/\/doi.org\/10.1089\/thy.2023.0564.","journal-title":"Thyroid"},{"issue":"12","key":"4357_CR33","doi-asserted-by":"publisher","first-page":"R577","DOI":"10.1530\/ERC-16-0067","volume":"23","author":"S Peiling Yang","year":"2016","unstructured":"Peiling Yang S, Ngeow J. Familial non-medullary thyroid cancer: unraveling the genetic maze. Endocrine-related Cancer. 2016;23(12):R577\u201395. https:\/\/doi.org\/10.1530\/ERC-16-0067.","journal-title":"Endocrine-related Cancer"},{"issue":"21","key":"4357_CR34","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMc1511631","volume":"373","author":"EY Zhou","year":"2015","unstructured":"Zhou EY, Lin Z, Yang Y. HABP2 Mutation and Nonmedullary Thyroid Cancer. N Engl J Med. 2015;373(21):2084\u20135. https:\/\/doi.org\/10.1056\/NEJMc1511631.","journal-title":"N Engl J Med"},{"key":"4357_CR35","unstructured":"WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours. Lyon (France): International Agency for Research on Cancer; 2025. (WHO classification of tumours series, 5th ed.; vol. 10). https:\/\/publications.iarc.who.int\/645."},{"issue":"2","key":"4357_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jso.23447","volume":"109","author":"YM Lee","year":"2014","unstructured":"Lee YM, Yoon JH, Yi O, Sung TY, Chung KW, Kim WB, Hong SJ. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. J Surg Oncol. 2014;109(2):168\u201373. https:\/\/doi.org\/10.1002\/jso.23447.","journal-title":"J Surg Oncol"},{"issue":"2","key":"4357_CR37","doi-asserted-by":"publisher","first-page":"E677","DOI":"10.1002\/lary.28989","volume":"131","author":"L Muallem Kalmovich","year":"2021","unstructured":"Muallem Kalmovich L, Jabarin B, Koren S, Or K, Marcus E, Tkacheva I, Benbassat C, Steinschneider M. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer? Laryngoscope. 2021;131(2):E677\u201381. https:\/\/doi.org\/10.1002\/lary.28989.","journal-title":"Laryngoscope"},{"issue":"5","key":"4357_CR38","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00268-005-0398-x","volume":"30","author":"F Triponez","year":"2006","unstructured":"Triponez F, Wong M, Sturgeon C, Caron N, Ginzinger DG, Segal MR, Kebebew E, Duh QY, Clark OH. Does familial non-medullary thyroid cancer adversely affect survival? World J Surg. 2006;30(5):787\u201393. https:\/\/doi.org\/10.1007\/s00268-005-0398-x.","journal-title":"World J Surg"},{"issue":"1","key":"4357_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/thy.2009.0406","volume":"21","author":"E Robenshtok","year":"2011","unstructured":"Robenshtok E, Tzvetov G, Grozinsky-Glasberg S, Shraga-Slutzky I, Weinstein R, Lazar L, Serov S, Singer J, Hirsch D, Shimon I, Benbassat C. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid. 2011;21(1):43\u20138. https:\/\/doi.org\/10.1089\/thy.2009.0406.","journal-title":"Thyroid"},{"issue":"6","key":"4357_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1089\/thy.2024.0588","volume":"35","author":"E Chuki","year":"2025","unstructured":"Chuki E, Behairy N, Auh S, Makarewicz A, Uttarkar Vikram CN, Kumari S, Veeraraghavan P, Cochran C, Gubbi S, Klubo-Gwiezdzinska J. Comparison of Progression-Free Survival in Familial Non-Medullary Thyroid Cancer and Sporadic Differentiated Thyroid Cancer Patients. Thyroid. 2025;35(6):642\u201351. https:\/\/doi.org\/10.1089\/thy.2024.0588.","journal-title":"Thyroid"},{"issue":"3","key":"4357_CR41","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1245\/s10434-020-09025-0","volume":"28","author":"YM Lee","year":"2021","unstructured":"Lee YM, Jeon MJ, Kim WW, Chung KW, Baek JH, Shong YK, Sung TY, Hong SJ. Comparison Between Familial and Sporadic Non-medullary Thyroid Carcinoma: A Retrospective Individual Risk Factor-Matched Cohort Study. Ann Surg Oncol. 2021;28(3):1722\u201330. https:\/\/doi.org\/10.1245\/s10434-020-09025-0.","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04357-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:04:43Z","timestamp":1781647483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04357-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4357"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04357-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients have given their written informed consent. All procedures in this study were reviewed and approved by the Clinical Trial and Biomedical Ethics Committee of West China Hospital of Sichuan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}